Citius Pharmaceuticals, Inc.
—- Market cap
- —
- Debt
- +$1.00M
- Cash
- −$4.25M
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · View financials
Decision snapshot: CTXR stock price vs MU: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at MU's multiple
Needs MU P/S.
Implied fair value · at CTXR's multiple
Needs CTXR P/S.
Metric by metric
Live quote
Price unavailable
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: CTXR FY 2022 (ended Sep 30, 2022) · MU FY 2025 (ended Aug 28, 2025). Fiscal years are not aligned.
Trendline
Eight fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Price framework
Discounted free cash flow, then bridged to a per-share price. Same assumptions applied to both companies.
Citius Pharmaceuticals, Inc. · implied price per share
Bear
$0.09
Base
$0.11
Bull
$0.13
Micron Technology, Inc. · implied price per share
Bear
$120.98
Base
$142.33
Bull
$163.68
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
0.01x
0.27x
Net debt / EBITDA
Leverage against operating earnings
0.09x
0.25x
Cash and equivalents
Liquid reserves on the balance sheet
$4.25M
$9.94B
Total debt
Interest-bearing obligations outstanding
$1.00M
$14.58B
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Zomedica Corp.
CTXR vs ZOM
Aquestive Therapeutics, Inc.
CTXR vs AQST
ACADIA PHARMACEUTICALS INC
CTXR vs ACAD
AMGEN INC
CTXR vs AMGN
GILEAD SCIENCES, INC.
CTXR vs GILD
AbbVie Inc.
CTXR vs ABBV
WESTERN DIGITAL CORP
CTXR vs WDC
Seagate Technology Holdings plc
CTXR vs STX
INTEL CORP
CTXR vs INTC
NVIDIA CORP
CTXR vs NVDA
Broadcom Inc.
CTXR vs AVGO
TEXAS INSTRUMENTS INC
CTXR vs TXN
Live quote
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.